Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 55 Next >>

Filter Applied: myasthenia gravis,treatment of (Click to remove)

Myasthenia Gravis in Mothers and Their Newborns
Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991

The Expanding Spectrum of Herpesvirus Infections of the Nervous System
Brain Pathol 11:440-451, Kleinschmidt-DeMasters,B.K. &Gilden,D.H., 2001

Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis
Neurol 98:e2368-e2376, Molimard, A.,et al, 2022

A New Option is Approved for Patients with Myasthenia Gravis
JAMA 327:417, Voelker, R., 2022

A Randomized Controlled Trial of Methotrexate for Patients with Generalized Myasthenia Gravis
Neurol 87:57-64, Pasnoor, M.,et al, 2016

International Consensus Guidance for Management of Myasthenia Gravis
Neurol 87:419-425, Sanders, D.B.,et al, 2016

Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016

The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome
JNNP 82:671-673, Maddison, P.,et al, 2011

Use and monitoring of low dose rituximab in myasthenia gravis
JNNP 82:659-663, Blum, S., et al, 2011

A Trial of Mycophenolate Mofetil With Prednisone as Initial Immunotherapy of Myasthenia Gravis
Neurol 71:394-399,390, The Muscle Study Group, 2008

An International, Phase III, Randomized Trial of Mycophenolate Mofetil in Myasthenia Gravis
Neurol 71:400-406, 390, Sanders,D.B.,et al., 2008

Treatment of Ocular Symptoms in Myasthenia Gravis
Neurol 71:1335-1341, Bhanushali,M.J.,et al, 2008

Immunosuppressant Drugs for Myasthenia Gravis
JNNP 80:5-6, Hart,I.K.,et al, 2008

Evidence Report: The Medical Treatment of Ocular Myasthenia (An Evidence-Based Review)
Neurol 68:2144-2149, Benatar,M. &Kaminski,H.J., 2007

Ocular Myasthenia: Diagnosis, Treatment and Pathogenesis
The Neurologist 12:231-239, Kusner,L.,et al, 2006

Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004

Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004

Treatment of Refractory Myasthenia: "Rebooting" with High-Dose Cyclophosphamide
Ann Neurol 53:29-34,7, Drachman,D.B.,et al, 2003

Treatment of Autoimmune Myasthenia Gravis
Neurol 61:1652-1661, Richman,D.P. & Agius,M.A., 2003

Steroid Treatment for Myasthenia Gravis
Muscle Nerve 25:115-121, Rivner,M.H., 2002

Thymoma in Patients with MG
Neurol 59:1844-1850, Evoli,A.,et al, 2002

Retrospective Analysis of the Use of Cyclosporine in Myasthenia Gravis
Neurol 55:448-450, Ciafaloni,E. et al, 2000

Association of Primary Central Nervous System Lymphoma with Long-Term Azathioprine Therapy for Myasthenia Gravis?
Ann Neurol 47: 682-683, Herrlinger,U.,et al, 2000

Course and Treatment of Myasthenia Gravis During Pregnancy
Neurol 52:447-452, Batocchi,A.P.,et al, 1999

A Randomized Double-Blind Trial of Prednisolone Alone or with Azathioprine in Myasthenia Gravis
Neurol 50:1778-1783, Palace,J.,et al, 1998

Successful Treatment of a Patient with Severe Refractory Myasthenia Gravis Using Mycophenolate Mofetil
Neurol 51:912-913, Hauser,R.A.,et al, 1998

Ocular Myasthenia Gravis:Response to Long Term Immunosuppressive Treatment
JNNP 62:156-162, Sommer,N.,et al, 1997

Treatment of Acquired Myasthenia Gravis
Neurol 48 (Suppl 5) :S46-S51997., Massey,J.M., 1997

Myasthenia Gravis
NEJM 330:1797-1810, Drachman,D.B., 1994

Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994

Total Body Irradiation for Myasthenia Gravis:A Long-Term Follow-up
Neurol 43:2215-2221, Durelli,L.,et al, 1993

Azathioprine Toxicity During Long-Term Immunosuppression of Generalized Myasthenia Gravis
Neurol 38:258-261, Hohlfeld,R.,et al, 1988

Myasthenis Gravis:Discontinuation of Long-Term Azathioprine
Ann Neurol 24:798, Michels,M.,et al, 1988

Preliminary Results of a Double-Blind Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia Gravis
NEJM 316:719-724, 743-7451987., Tindall,R.S.A.,et al, 1987

Prednisone-Induced Worsening of Neuromuscular Function in Myasthenia Gravis
Neurol 36:729-732, Miller,R.G.,et al, 1986

Immunosuppressive Drug Therapy in Myasthenia Gravis
Arch Neurol 43:155-156, Niakan,E.,et al, 1986

High-Dose Intravenous Methylprednisolone in Myasthenia Gravis
Arch Neurol 42:1149-1153, Arsura,E.,et al, 1985

Long-Term Corticosteroid Treatment of Myasthenia Gravis:Report of 116 Patients
Ann Neurol 15:291-298, Pascuzzi,R.M.,et al, 1984

Myasthenia Gravis:Prolonged Treatment with Steroids
Neurol 34:170-174, Sghirlanzoni,A.,et al, 1984

Azathioprine in the Treatment of Myasthenia Gravis
Ann Neurol 15:602-605, Witte,A.S.,et al, 1984

Myasthenia Gravis & Myasthenic Syndromes
Ann Neurol 16:519-534, Engel,A.G., 1984

Ventilatory Failure in Myasthenia Gravis
JNNP 45:217-222, Ferguson,I.T.,et al, 1982

Treatment with Oral 4-aminopyridine in Disorders of Neuromuscular Transmission
Neurol 31:265-271, Murray,N.M.F.,et al, 1981

Stable Remissions in Myasthenia Gravis
Neurol 31:32-37, Perez,M.C.,et al, 1981

Ocular Myasthenia:Diagnosis & Therapy
In Neuro-Ophthalmology, Vol X ed. by J. Glaser. CV Mosby Co, St. Louis, Daroff,R., 1980

Controversies About the Treatment of Myasthenia Gravis
JNNP 43:644-659, Rowland,L.P., 1980

Prednisone Use in Concurrent Autoimmune Diseases
Arch Neurol 36:103-106, Harati,Y.,et al, 1979

Myasthenia Gravis Treated with Purified Antithymocyte Antiserum
Neurol 29:112-116, Pirofsky,B.,et al, 1979

Myasthenia Gravis
NEJM 298:136, Drachman,D.B., 1978



Showing articles 0 to 50 of 55 Next >>